Affymetrix (Santa Clara, California) to Commercialize Powerful Genotyping Array for Chinese Population

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix, Inc. (NASDAQ:AFFX) today announced that it will develop and commercialize the Axiom™ Chinese myDesign™ Genotyping Array, the first product that provides maximum power for genome-wide association studies (GWAS) specifically on Chinese populations.